Company / Operating Cash Flow per Share
Evolent Health, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.35
FY2025
5-year range
-$0.14 / $1.66
FY2021-FY2025
Trend
+74.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-15.35 in FY2016 to $1.66 in FY2023.
Based on SEC 10-K filings.
0.35 in FY2025.
Declined from $1.66 to $0.35 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 74.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.35 | +74.3% |
| FY2024 | $0.20 | -87.9% |
| FY2023 | $1.66 | +1317.8% |
| FY2022 | -$0.14 | -128.9% |
| FY2021 | $0.47 | +324.2% |
| FY2020 | -$0.21 | +68.3% |
| FY2019 | -$0.66 | -44.5% |
| FY2018 | -$0.46 | +24.3% |
| FY2017 | -$0.61 | +96.1% |
| FY2016 | -$15.35 | -148.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026